A prospective natural history study of inclusion body myositis
- 14 August 2001
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 57 (3) , 548-550
Abstract
Eleven patients with untreated inclusion body myositis (IBM) were prospectively studied during a 6-month period that included muscle strength, lean body mass, and muscle mass measurements. There was an overall quantifiable mean decline in percent of predicted normal muscle strength of 4% from baseline in a 6-month period, but one third of patients showed no change or slight improvements in strength. Short-term treatment trials in IBM will require large numbers of patients to detect slowing, arrest, or even slight improvement in muscle strength.Keywords
This publication has 9 references indexed in Scilit:
- Disease progression in sporadic inclusion body myositis: Observations in 78 patientsNeurology, 2000
- Targeted Somatic Mutagenesis in Mouse EpidermisHormone Research in Paediatrics, 2000
- A Prospective, Quantitative Study of the Natural History of Facioscapulohumeral Muscular Dystrophy (FSHD)Neurology, 1997
- Inclusion body myositis and myopathiesAnnals of Neurology, 1995
- Facioscapulohumeral Dystrophy Natural History Study: Standardization of Testing Procedures and Reliability of MeasurementsPhysical Therapy, 1994
- The Treatment of Inclusion Body MyositisMedicine, 1993
- INCLUSION BODY MYOSITISBrain, 1989
- The assessment of muscle mass in progressive neuromuscular diseaseNeurology, 1983
- Estimation of Total Body Fat from Potassium-40 ContentScience, 1961